Calabrò, Paolo

Effect of body mass index reduction on serum hepcidin levels and iron status in obese children

Amato, A., Santoro, N., Calabrò, P., Grandone, A., Swinkels, D. W., Perrone, L., & Miraglia del Giudice, E. (2010) · International Journal of Obesity

Iron Metabolism and DisordersAdipokines, Inflammation, and Metabolic Diseases

Cited by 115

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis

Agarwal, R., Tu, W., Farjat, A. E., Farag, Y. M. K., Toto, R., Kaul, S., Lawatscheck, R., Rohwedder, K., Ruilope, L. M., Rossing, P., et al. (2023) · Annals of Internal Medicine

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 109

Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence

Caturano, A., Galiero, R., Pafundi, P. C., Cesaro, A., Vetrano, E., Palmiero, G., Rinaldi, L., Salvatore, T., Marfella, R., Sardu, C., et al. (2021) · Diabetes Research and Clinical Practice

Hyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Treatment and Management

Cited by 73

FLOW trial stopped early due to evidence of renal protection with semaglutide

Gragnano, F., De Sio, V., & Calabrò, P. (2024) · European Heart Journal - Cardiovascular Pharmacotherapy

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 51

Reduction of visit-to-visit LDL-C intraindividual variability in patients treated with PCSK9 inhibitors and inclisiran vs standard lipid-lowering therapy

Cesaro, A., Acerbo, V., Scialla, F., Zito, A., Porcelli, G., Panico, D., Argenziano, G., Iaria, D., Monaco, M. G., De Sio, V., et al. (2026) · Journal of Clinical Lipidology

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 11

Challenges in achieving LDL-C goals: Insights from the Italian SANTORINI study cohort

Arca, M., Calabrò, P., Solini, A., Pirillo, A., Gambacurta, R., Ray, K. K., & Catapano, A. L. (2026) · Nutrition, Metabolism and Cardiovascular Diseases

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3